• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中毒性休克综合征患者的纤溶变化;活性尿激酶型纤溶酶原激活物的释放

Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA.

作者信息

Haj M A, Robbie L A, Croll A, Adey G D, Bennett B

机构信息

Department of Medicine & Therapeutics, University of Aberdeen Medical School, Foresterhill UK.

出版信息

Intensive Care Med. 1998 Mar;24(3):258-61. doi: 10.1007/s001340050561.

DOI:10.1007/s001340050561
PMID:9565810
Abstract

OBJECTIVE

Definition of the changes in the activators of plasminogen, u-PA and t-PA, and examination of the possible generation of plasmin in the circulation in overwhelming sepsis.

DESIGN

Serial blood analysis starting 4 h after development of symptoms of toxic shock syndrome.

SETTING

Intensive care unit.

PATIENT

A previously healthy woman underwent endometrial ablation and rapidly thereafter developed staphylococcal toxic shock syndrome with organ failure. MEASUREMENT AND RESULT: t-PA, PAI-1, t-PA-PAI-1 complexes, plasminogen, fibrinogen and plasmin-alpha 2-antiplasmin complexes were measured serially by ELISA and free u-PA by SDS-PAGE with zymography. The onset of symptoms was accompanied by a rise of t-PA antigen-followed rapidly by PAI-1 antigen. Plasmin-alpha 2-antiplasmin complex was generated in large amounts but disappeared within hours. From day 3, free u-PA was detectable in the circulation without plasmin generation.

CONCLUSION

Despite the sustained presence of active u-PA in the circulation and of t-PA antigen at the onset of symptoms, plasmin-alpha 2-antiplasmin generation was largely suppressed by high levels of PAI-1. The suppression of plasmin generation by u-PA and t-PA may ensure the persistence of fibrin in the microcirculation and so contribute to organ failure.

摘要

目的

明确纤溶酶原激活剂尿激酶型纤溶酶原激活剂(u-PA)和组织型纤溶酶原激活剂(t-PA)的变化,并检测暴发性脓毒症时循环中纤溶酶的可能生成情况。

设计

在中毒性休克综合征症状出现后4小时开始进行系列血液分析。

地点

重症监护病房。

患者

一名既往健康的女性接受了子宫内膜切除术,此后迅速发展为伴有器官衰竭的葡萄球菌中毒性休克综合征。

测量与结果

通过酶联免疫吸附测定(ELISA)连续检测t-PA、纤溶酶原激活物抑制剂-1(PAI-1)、t-PA-PAI-1复合物、纤溶酶原、纤维蛋白原和纤溶酶-α2-抗纤溶酶复合物,通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和酶谱法检测游离u-PA。症状出现时伴有t-PA抗原升高,随后PAI-1抗原迅速升高。大量生成纤溶酶-α2-抗纤溶酶复合物,但数小时内消失。从第3天起,循环中可检测到游离u-PA,但无纤溶酶生成。

结论

尽管症状出现时循环中持续存在活性u-PA和t-PA抗原,但高水平的PAI-1在很大程度上抑制了纤溶酶-α2-抗纤溶酶的生成。u-PA和t-PA对纤溶酶生成的抑制可能确保纤维蛋白在微循环中的持续存在,从而导致器官衰竭。

相似文献

1
Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA.中毒性休克综合征患者的纤溶变化;活性尿激酶型纤溶酶原激活物的释放
Intensive Care Med. 1998 Mar;24(3):258-61. doi: 10.1007/s001340050561.
2
Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis.
Br J Haematol. 2000 May;109(2):342-8. doi: 10.1046/j.1365-2141.2000.02057.x.
3
Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.某些骨髓增殖性综合征中的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及纤溶酶原激活剂抑制剂(PAI - 1和PAI - 2)
Med Sci Monit. 2000 Jul-Aug;6(4):684-91.
4
Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.人类肿瘤坏死因子输注期间纤维蛋白溶解的进展。组织型纤溶酶原激活物、1型纤溶酶原激活物抑制剂和纤维蛋白(原)降解产物同时增加。
Blood. 1990 Dec 1;76(11):2284-9.
5
Mechanisms of physiological fibrinolysis.生理性纤维蛋白溶解机制。
Baillieres Clin Haematol. 1995 Jun;8(2):277-90. doi: 10.1016/s0950-3536(05)80268-9.
6
[Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].[闭塞性动脉粥样硬化症和糖尿病大血管病变患者的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及其他纤溶参数]
Pol Merkur Lekarski. 2001 Nov;11(65):414-7.
7
Interference of an activity assay of tissue-type plasminogen activator in human plasma by endogenous factors.
Blood Coagul Fibrinolysis. 1996 Jun;7(4):491-6. doi: 10.1097/00001721-199606000-00010.
8
Fibrinolysis system in patients with bronchial asthma.支气管哮喘患者的纤溶系统
Med Sci Monit. 2000 Jan-Feb;6(1):103-7.
9
Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow.急性髓系白血病骨髓中的纤溶酶原激活剂:与正常骨髓中的组织型纤溶酶原激活剂(t-PA)不同,尿激酶型纤溶酶原激活剂(u-PA)存在。
Br J Haematol. 1998 Jun;101(4):626-31. doi: 10.1046/j.1365-2141.1998.00762.x.
10
Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.患有魁北克血小板紊乱症的患者的血小板含有并分泌异常量的尿激酶型纤溶酶原激活剂。
Blood. 2001 Jul 15;98(2):257-65. doi: 10.1182/blood.v98.2.257.

引用本文的文献

1
Effects of extracellular DNA on plasminogen activation and fibrinolysis.细胞外 DNA 对纤溶酶原激活和纤维蛋白溶解的影响。
J Biol Chem. 2011 Dec 9;286(49):41949-41962. doi: 10.1074/jbc.M111.301218. Epub 2011 Oct 5.

本文引用的文献

1
Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients.脓毒症患者中性粒细胞和单核细胞中纤溶酶原激活物抑制剂
Thromb Haemost. 1995 Dec;74(6):1528-32.
2
Evidence for an active fibrinolytic system in normal human bone marrow.正常人类骨髓中存在活跃纤维蛋白溶解系统的证据。
Br J Haematol. 1996 Apr;93(1):170-6. doi: 10.1046/j.1365-2141.1996.442985.x.
3
A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.一种与中毒性休克综合征金黄色葡萄球菌分离株相关的新型葡萄球菌肠毒素——肠毒素F。
Lancet. 1981 May 9;1(8228):1017-21. doi: 10.1016/s0140-6736(81)92186-3.
4
Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.人肝细胞和肝癌细胞系Hep G2的条件培养基对纤溶酶原激活剂的抑制作用。
J Lab Clin Med. 1985 Jun;105(6):751-8.
5
Plasminogen activator inhibitor 1: a new prognostic marker in septic shock.纤溶酶原激活物抑制剂1:脓毒性休克中的一种新的预后标志物。
Thromb Haemost. 1989 Jun 30;61(3):459-62.
6
The toxic shock syndrome.中毒性休克综合征
BMJ. 1990 Apr 14;300(6730):960. doi: 10.1136/bmj.300.6730.960.
7
Fibrinolysis and coagulation in patients with infectious disease and sepsis.传染病和脓毒症患者的纤维蛋白溶解与凝血
Thromb Haemost. 1991 Mar 4;65(3):291-5.
8
Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor.组织型纤溶酶原激活物与纤溶酶原激活物抑制剂-1、α2-巨球蛋白及C1抑制物的复合物形成:电击或复杂分娩后去纤维蛋白和纤溶状态患者的研究
Blood. 1990 Feb 1;75(3):671-6.
9
Granulocyte elastase, tumor necrosis factor-alpha and urokinase levels as prognostic markers in severe infection.粒细胞弹性蛋白酶、肿瘤坏死因子-α及尿激酶水平作为严重感染的预后标志物
Thromb Haemost. 1992 Jul 6;68(1):19-23.
10
Cathepsin G, a polymorphonuclear cell protease, affects the fibrinolytic system by releasing PAI-1 from endothelial cells and platelets.组织蛋白酶G是一种多形核细胞蛋白酶,它通过从内皮细胞和血小板中释放纤溶酶原激活物抑制剂-1(PAI-1)来影响纤维蛋白溶解系统。
Ann N Y Acad Sci. 1992 Dec 4;667:286-8. doi: 10.1111/j.1749-6632.1992.tb51628.x.